These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3270508)

  • 1. Hydroxyurea and etoposide: in vitro synergy and phase I clinical trial.
    Ratain MJ; Schilsky RL; Wojack BR; Simon T; Senekjian EK; Vogelzang NJ
    J Natl Cancer Inst; 1988 Nov; 80(17):1412-6. PubMed ID: 3270508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxic synergy of cisplatin with concurrent hydroxyurea and cytarabine: summary of an in vitro model and initial clinical pilot experience.
    Albain KS; Swinnen LJ; Erickson LC; Stiff PJ; Fisher SG; Fisher RI
    Semin Oncol; 1992 Jun; 19(3 Suppl 9):102-9. PubMed ID: 1641650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I/II study incorporating intravenous hydroxyurea into high-dose chemotherapy for patients with primary refractory or relapsed and refractory intermediate-grade and high-grade malignant lymphoma.
    Vaughan WP; Kris E; Vose J; Bierman PJ; Gwilt P; Armitage JO
    J Clin Oncol; 1995 May; 13(5):1089-95. PubMed ID: 7738614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I study of vincristine and escalating doses of etoposide.
    Jackson DV; Cruz JM; Zekan PJ; Caponera ME; Spurr CL; White DR; Richards F; Muss HB
    Invest New Drugs; 1989 Jul; 7(2-3):203-7. PubMed ID: 2793373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination chemotherapy with hydroxyurea, dacarbazine (DTIC), and etoposide in the treatment of uterine leiomyosarcoma: a Gynecologic Oncology Group study.
    Currie J; Blessing JA; Muss HB; Fowler J; Berman M; Burke TW
    Gynecol Oncol; 1996 Apr; 61(1):27-30. PubMed ID: 8626112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I trial of cytarabine and hydroxyurea.
    Pfeifle CE; Howell SB
    Cancer Treat Rep; 1983 Dec; 67(12):1127-9. PubMed ID: 6652629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I study of paclitaxel with oral etoposide in advanced solid tumors.
    Perez EA; Coe T; Turrell C; Lau D; Campbell D; Gandara D
    Cancer J Sci Am; 1996; 2(5):286-90. PubMed ID: 9166546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxic synergism between trimetrexate and etoposide. Evidence that trimetrexate potentiates etoposide-induced protein-associated DNA strand breaks in L1210 leukemia cells through alterations in intracellular ATP concentrations.
    Fry DW
    Biochem Pharmacol; 1990 Nov; 40(9):1981-8. PubMed ID: 2146963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxyurea, fluorouracil, and concomitant radiotherapy in poor-prognosis head and neck cancer: a phase I-II study.
    Vokes EE; Panje WR; Schilsky RL; Mick R; Awan AM; Moran WJ; Goldman MD; Tybor AG; Weichselbaum RR
    J Clin Oncol; 1989 Jun; 7(6):761-8. PubMed ID: 2715806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laboratory and clinical studies of biochemical modulation by hydroxyurea.
    Schilsky RL; Ratain MJ; Vokes EE; Vogelzang NJ; Anderson J; Peterson BA
    Semin Oncol; 1992 Jun; 19(3 Suppl 9):84-9. PubMed ID: 1641659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paclitaxel, 5-fluorouracil, hydroxyurea, and concomitant radiation therapy for poor-prognosis head and neck cancer.
    Vokes EE; Haraf DJ; Brockstein BE; Weichselbaum RR
    Semin Radiat Oncol; 1999 Apr; 9(2 Suppl 1):70-6. PubMed ID: 10210543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I and pharmacokinetic trial of intraperitoneal etoposide in combination with the multidrug-resistance-modulating agent dipyridamole.
    Isonishi S; Kirmani S; Kim S; Plaxe SC; Braly PS; McClay EF; Howell SB
    J Natl Cancer Inst; 1991 May; 83(9):621-6. PubMed ID: 2023280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential hydroxyurea-cytarabine chemotherapy for refractory non-Hodgkin's lymphoma.
    Schilsky RL; Williams SF; Ultmann JE; Watson S
    J Clin Oncol; 1987 Mar; 5(3):419-25. PubMed ID: 3819808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase I study of cisplatin, etoposide, and paclitaxel in small cell lung cancer.
    Bunn PA; Kelly K
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-144-S12-148. PubMed ID: 9331140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase I trial of concomitant chemoradiotherapy with cisplatin dose intensification and granulocyte-colony stimulating factor support for advanced malignancies of the chest.
    Vokes EE; Haraf DJ; Drinkard LC; Hoffman PC; Ferguson MK; Vogelzang NJ; Watson S; Lane NJ; Golomb HM
    Cancer Chemother Pharmacol; 1995; 35(4):304-12. PubMed ID: 7530173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I study of high-dose cytosine arabinoside and etoposide in patients with advanced malignancies.
    Powell BL; Muss HB; Capizzi RL; Caponera ME; White DR; Zekan PJ; Atkins JN; Jackson DV; Richards F; Craig JB
    Cancer Chemother Pharmacol; 1987; 19(3):250-2. PubMed ID: 3581419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Combination effects of etoposide with other antitumor drugs in vitro and in vivo].
    Nishikawa K; Kusama K; Ekimoto H; Takahashi K
    Gan To Kagaku Ryoho; 1989 Dec; 16(12):3739-45. PubMed ID: 2596858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose hydroxyurea in autologous bone marrow transplantation: a promising "new" agent.
    Vaughan WP; Bierman PJ; Reed EC; Glenn LD; Kessinger A; Armitage JO
    Semin Oncol; 1992 Jun; 19(3 Suppl 9):110-5. PubMed ID: 1641652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase I trial of carboplatin and etoposide given as continuous infusions to adults with leukemia.
    Lee EJ; Reck K; Carter C; Hodges S; Schiffer CA
    Leukemia; 1993 Oct; 7(10):1500-3. PubMed ID: 8412310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase I study of paclitaxel, etoposide, and cisplatin in extensive stage small cell lung cancer.
    Kelly K; Pan Z; Wood ME; Murphy J; Bunn PA
    Clin Cancer Res; 1999 Nov; 5(11):3419-24. PubMed ID: 10589753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.